Issued 2026-09-16 at $10.36 · now $10.36 (2026-09-16, +0.0% since)
Based on its own history, a month from the 2026-09-16 close, DEI has typically landed between $8.80 and $11.84 — a range of −15.1% to +14.3% from the issuance price $10.36.
- Actual close
- Typical path (median)
- Middle 50% of outcomes
- 90% range
4,983 overlapping 1 month windows · 2006-10-24 – 2026-08-17 · basis climatology · forecast (batch). Probability up 53.9% (90% CI 51.7–56.1%, ≈1,408 obs).
The cone is anchored at the 2026-09-16 issuance close ($10.36) — the price the forecast resolves against on 2026-10-15, not the latest close. The drawn path shape is illustrative (bands widen with √t); every labeled number is real — the anchor, the scored batch p90/IQR endpoints, and the typical move.
Where DEI has typically landed a month from the 2026-09-16 close of $10.36 — the range is history, not a prediction.
- now $10.36 (+0.0%)
- typicalThe typical outcome — half of similar past periods did better and half did worse (not an average, so a few wild periods don't skew it). $10.2 (-1.5%)
- middle 50%The central range of outcomes — half of similar past periods landed inside it, a quarter finished above, a quarter below. $9.59–$10.81
- 90% rangeA nine-in-ten range — in about nine of every ten similar past periods the outcome stayed within these bounds. $8.8–$11.84
| Start | Return | Max drop | Max rise |
|---|---|---|---|
| 3 worst | |||
| 2008-09-26 | −50.7% | −50.7% | +0.0% |
| 2008-09-25 | −45.7% | −45.7% | +3.5% |
| 2020-02-21 | −44.8% | −44.8% | +0.0% |
| 3 best | |||
| 2008-12-01 | +60.4% | +0.0% | +66.0% |
| 2008-12-04 | +55.7% | +0.0% | +55.7% |
| 2009-07-09 | +53.4% | −1.6% | +53.4% |
4,983 overlapping windows · 2006-10-24 – 2026-09-16 · not cherry-picked
Seasonality · by month iHow this security has tended to do in each calendar month historically — a frequency, never a prediction.
iFor each calendar month, the share of years this security closed higher than the month before, and the average month-over-month return, over ~20 years of its own price history. Cells are shaded by average return. This is historical frequency, not a prediction — no month is a signal.Up-frequency and average month-over-month return · historical frequency, not a prediction
Reported insider & political trades
Every Form 4 the people closest to this company have filed with the SEC — plotted against the share price, aggregated by month, and shown with the gap between when each trade happened and when it was disclosed. A public record, not advice.
| Date | Person | Role | Action | Shares @ price | Value | Ownership Δ | vs S&P 1m | vs S&P 6m | Owned after | Filing |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-13 | Kaplan Jordan L | director | Purchase | 98,000 @ $10.18 | $998K | +3.4% of holding | −1.7% | +5.2% | 2,949,640 | Form 4 · filed 5 days after the trade |
| 2025-11-17 | Aronson Michele L | officer | Purchase | 34,626 @ $11.68 | $404K | +461.7% of holding | −2.4% | −7.9% | 42,126 | Form 4 · filed 1 day after the trade |
| 2025-11-14 | Aronson Michele L | officer | Purchase | 7,500 @ $11.75 | $88K | ownership Δ n/a | −4.1% | −10.4% | 7,500 | Form 4 · filed 4 days after the trade |
The vs-S&P columns are a labeled look-back on what the stock did after each filing, measured against the index over the same window. Descriptive history, not a claim about the person or a reason to trade.
24 award / exercise / gift records — not counted as purchases
Awards, option exercises, gifts and tax-withholding disposals are shown separately and never counted as open-market purchases or sales — they carry no conviction information.
| Date | Person | Role | Action | Shares | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2025-12-15 | Aronson Michele L | officer | Award / grant | 222,794 | 222,794 | Form 4 |
| 2025-12-15 | O HERN THOMAS E | director | Award / grant | 20,780 | 20,780 | Form 4 |
| 2025-12-15 | Panzer Kenneth M | director | Award / grant | 1,011,140 | 1,011,140 | Form 4 |
| 2025-12-15 | Wang Shirley | director | Award / grant | 18,852 | 18,852 | Form 4 |
| 2025-12-15 | MCFERRAN VIRGINIA | director | Award / grant | 20,138 | 20,138 | Form 4 |
| 2025-12-15 | CRUMMY KEVIN ANDREW | officer | Award / grant | 124,251 | 124,251 | Form 4 |
| 2025-12-15 | Bider Leslie E | director | Award / grant | 20,138 | 20,138 | Form 4 |
| 2025-12-15 | Kaplan Jordan L | director | Award / grant | 1,011,140 | 1,011,140 | Form 4 |
| 2025-12-15 | Dominguez Dorene | director | Award / grant | 18,852 | 18,852 | Form 4 |
| 2025-12-15 | SIMON WILLIAM E JR | director | Award / grant | 18,852 | 18,852 | Form 4 |
| 2025-12-15 | SEYMOUR PETER | officer | Award / grant | 214,225 | 214,225 | Form 4 |
| 2024-12-12 | Emmett Dan A | director | Award / grant | 13,699 | 13,699 | Form 4 |
| 2024-12-12 | Leonard Ray C | director | Award / grant | 11,162 | 11,162 | Form 4 |
| 2024-12-12 | Dominguez Dorene | director | Award / grant | 11,162 | 11,162 | Form 4 |
| 2024-12-12 | Kaplan Jordan L | director | Award / grant | 598,681 | 598,681 | Form 4 |
| 2024-12-12 | Panzer Kenneth M | director | Award / grant | 598,681 | 598,681 | Form 4 |
| 2024-12-12 | SIMON WILLIAM E JR | director | Award / grant | 11,162 | 11,162 | Form 4 |
| 2024-12-12 | Bider Leslie E | director | Award / grant | 11,923 | 11,923 | Form 4 |
| 2024-12-12 | SEYMOUR PETER | officer | Award / grant | 115,424 | 115,424 | Form 4 |
| 2024-12-12 | CRUMMY KEVIN ANDREW | officer | Award / grant | 96,398 | 96,398 | Form 4 |
| 2024-12-12 | Aronson Michele L | officer | Award / grant | 114,156 | 114,156 | Form 4 |
| 2024-12-12 | Wang Shirley | director | Award / grant | 11,162 | 11,162 | Form 4 |
| 2024-12-12 | MCFERRAN VIRGINIA | director | Award / grant | 11,923 | 11,923 | Form 4 |
| 2024-12-12 | O HERN THOMAS E | director | Award / grant | 12,304 | 12,304 | Form 4 |
Source: SEC Form 4 filings. Each row links to its original filing.
Across 2012–2021, stocks where a CEO, C-suite officer, or director had recently made an open-market common-stock purchase ran about +28 bp per month above the universe average (n=34,268 stock-weeks). A historical tendency, not a prediction.
Congressional disclosures
No congressional trades disclosed for this company.
Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.